Skip to main content

Table 1 miR-361-3p expression and clinicopathological features in non-small cell lung cancer (NSCLC) patients

From: MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC

Variables n miR-361-3p expression  
High expression Low expression p value*
Gender
 Male 67 27(40 %) 40(60 %)  
 Female 24 6(25 %) 18(75 %) 0.181
Age(years)
  > 55 56 20(36 %) 36(64 %)  
55 35 13(37 %) 22(63 %) 0.890
Smoking history
 Yes 54 20(37 %) 34(63 %)  
 No 37 13(35 %) 24(65 %) 0.853
Pathological type
 Adenocarcinoma 54 18(34 %) 36(66 %)  
 Squamous carcinoma 37 15(41 %) 22(59 %) 0.482
Tumor differentiation
 High 22 10(45 %) 22(55 %)  
 Middle 58 21(36 %) 37(64 %)  
 Low 11 2(18 %) 9(82 %) 0.307
Tumor location
 Right lung 45 17(38 %) 28(62 %)  
 Left lung 46 16(35 %) 30(65 %) 0.766
Tumor size(cm)
  > 3 54 17(31 %) 27(69 %)  
3 37 16(43 %) 21(57 %) 0.252
Lymphatic metastasis
 Yes 42 8(19 %) 34(81 %)  
 No 49 23(47 %) 26(53 %) 0.002
TNM classification
 I 43 22(51 %) 21(49 %)  
 II 22 6(27 %) 16(73 %)  
 III + IV 26 5(19 %) 21(81 %) 0.017
  1. Abbreviations: TNM tumor-node-metastasis
  2. * χ2test